Fidelity Biopharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FIDELITY BIOPHARMA
FIDELITY BIOPHARMA has one approved drug.
There are two US patents protecting FIDELITY BIOPHARMA drugs.
There are nine patent family members on FIDELITY BIOPHARMA drugs in seven countries.
Summary for Fidelity Biopharma
| International Patents: | 9 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Fidelity Biopharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Biopharma | ONTRALFY | tizanidine hydrochloride | SOLUTION;ORAL | 216190-001 | Dec 12, 2024 | RX | Yes | Yes | 12,263,158 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Fidelity Biopharma | ONTRALFY | tizanidine hydrochloride | SOLUTION;ORAL | 216190-001 | Dec 12, 2024 | RX | Yes | Yes | 12,042,484 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Fidelity Biopharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2022247609 | ⤷ Start Trial |
| Japan | 7627353 | ⤷ Start Trial |
| China | 120241723 | ⤷ Start Trial |
| Australia | 2022280757 | ⤷ Start Trial |
| South Korea | 20240006523 | ⤷ Start Trial |
| China | 115400123 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
